Get investor ideas from our AI, cannabis, cleantech, crypto, gaming, mining, sports podcasts - be a guest or sponsor: call 800 665 0411

Share on StockTwits

AI Eye Podcast 615: Stocks discussed: (OTC: $RHHBY) (NasdaqGS: $MDRX)

Roche Enters Agreement with Ibex Medical Analytics for AI-Based Digital Pathology Applications, and Allscripts Healthcare Solutions Launches Guided Scheduling


Point Roberts, WA and Vancouver, BC - October 18, 2021 ( Newswire) (, a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today's podcast:

AI Eye Podcast 615: Stocks discussed: (OTC: $RHHBY) (NasdaqGS: $MDRX)


Hear the AI Eye on Spotify

Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTC:RHHBY) (NasdaqGS:MDRX)

Pathology lab solutions provider Roche Holding AG (OTC:RHHBY) has entered an agreement with AI-based cancer diagnostics firm Ibex Medical Analytics to jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex's AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche's uPath enterprise software. Jill German, Head of Roche Diagnostics Pathology Customer Area, said:

"With the addition of Ibex's clinical-grade image analysis tools to our NAVIFY Digital Pathology menu, we can aid pathologists and providers in delivering value-based patient care by increasing their efficiency and accuracy for higher quality cancer diagnosis."

Allscripts Healthcare Solutions, Inc. (NasdaqGS:MDRX) has announced the launch of Guided Scheduling, described in the press release as "an artificial intelligence scheduling application that uses real-time provider, practice, and industry data to optimize providers' days." Launching in Allscripts Practice Management, the application considers "key clinical and operational metrics," resulting in faster care and "the improved utilization of all resources across an organization." Tina Joros, Allscripts Vice President and General Manager for Allscripts Practice Management, commented:

"I am very pleased for Allscripts to deliver Allscripts Guided Scheduling to our clients in our latest release. Leveraging real-time data, artificial intelligence, and proven principles from other industries can be a game changer for our clients and the entire healthcare market. Our goal is to continuously enhance our solutions to help our clients meet their practice goals and Guided Scheduling is a tool that can help them significantly in this effort."

Global AI in Cybersecurity Market to Reach $42.5B in 2027

A report published by Research and Markets finds that the global AI in Cybersecurity market is projected to grow from $9.2 billion USD in 2017 to $42.5 billion in 2027 with a compound annual growth rate (CAGR) of 16.5 percent in the forecast period. An excerpt from the report's description outlines some factors driving the market's growth:

The number of start-ups adopting artificial intelligence has increased substantially from the past few years and is expected to boost the global artificial intelligence in Cybersecurity market growth over the forecast period. Existing organizations are also exploring the possibility of adopting artificial intelligence into their systems to leverage its various benefits. The increase in demand for advanced Cybersecurity solutions and privacy will positively influence the market growth. Also, the increase in frequency and complexity of cyber threats, emergence of disruptive digital technologies across the industry verticals is expected to drive the global artificial intelligence in Cybersecurity market growth.

Sam Mowers,

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on visit here or become an Investor Ideas member

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

About - News that Inspires Big Investing Ideas publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea's original branded content includes podcasts and columns: Crypto Corner, Play by Play sports and stock news, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast, Cleantech and Climate Change, Exploring Mining, Betting on Gaming Stocks Podcast and the AI Eye Podcast.

The podcasts are also available on iTunes (Apple Podcasts), Audible , Spotify, Tunein, Stitcher,, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and Global investors must adhere to regulations of each country. Please read privacy policy:

The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of

Follow us on Twitter

Follow us on Facebook

Follow us on YouTube

Download our Mobile App for iPhone and Android


800 665 0411

Get more tech stocks investor ideas - news, articles, podcasts and stock directories

Buy a technology guest post on